Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα.
Gastroenterology
; 162(2): 454-467, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34717923
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Immunogenicity, Vaccine
/
Tumor Necrosis Factor Inhibitors
/
COVID-19
/
BNT162 Vaccine
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Gastroenterology
Year:
2022
Type:
Article
Affiliation country:
Israel